Warning: Undefined variable $zfal in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Deprecated: str_replace(): Passing null to parameter #3 ($subject) of type array|string is deprecated in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 530
 free
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 531
 free
 free
 
English Wikipedia
Nephropedia Template TP (
Twit Text
DeepDyve
Pubget Overpricing |  
lüll
Pharmacologic treatment of migraine Comparison of guidelines Schuurmans A; van Weel CCan Fam Physician 2005[Jun]; 51 (6): 838-43OBJECTIVE: To compare guidelines (not the primary studies) for pharmacologic treatment of migraine as to methods of guideline development; recommendations, particularly on triptans; and quality of supporting evidence (with emphasis on comparative studies of triptans versus ergot alkaloids and nonsteroidal anti-inflammatory drugs [NSAIDs]). DATA SOURCES: We searched MEDLINE via PubMed for guidelines on migraine management published since 1990 in any language; in addition, we browsed the Internet for information. STUDY SELECTION: We found nine clinical guidelines on migraine; one guideline, not supported by references, was excluded. SYNTHESIS: Preference for triptans is not well founded and is largely based on comparisons with placebo. Too few studies compared new drugs with established ones (NSAIDs or dihydroergotamine). Guidelines that propose a hierarchy for selection of drugs are opinion-based rather than evidence-based. CONCLUSION: The current lack of evidence from comparative studies seriously limits development of evidence-based clinical practice guidelines for pharmacologic treatment of migraine.|*Practice Guidelines as Topic[MESH]|Analgesics, Non-Narcotic/*therapeutic use[MESH]|Anti-Inflammatory Agents, Non-Steroidal/therapeutic use[MESH]|Antiemetics/*therapeutic use[MESH]|Ergotamines/therapeutic use[MESH]|Humans[MESH]|Migraine Disorders/*drug therapy[MESH]|Serotonin Receptor Agonists/*therapeutic use[MESH]|Sumatriptan/therapeutic use[MESH] |
